ApoC-II mimetic peptides

US11136372B2 · kind B2 · utility

Assignees

• The United States of America as Represented by the Secretary, Dept. of Health and Human Services · US
• Novo Nordisk A/S · DK

Inventors

• Alan T. Remaley · Bethesda, US
• Soumitra S. Ghosh · San Diego, US
• Madhav Narasimha Devalaraja · Acton, US
• Chih-Hung Lo · Rockville, US
• Denis O. Sviridov · Rockville, US
• Anna Wolska · Washington, US

Key dates

• Filing date: Jan 19, 2018
• Grant date: Oct 5, 2021
• Expiry date: Jan 19, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2319/42
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.